Levi Winkelman
PhD candidate
- Name
- L.M.T. Winkelman MSc
- Telephone
- 071 5276274
- l.m.t.winkelman@lacdr.leidenuniv.nl
- ORCID iD
- null
PhD candidate
- LACDR
- Divisie Cell systems and Drug Safety
- Durnik R., Juchelkova T., Hecht H., Winkelman L.M.T., Beltman J.B., Coumoul X., Jornod F., Audouze K., Blaha L. & Bajard L. (2026), Towards Bayesian-based quantitative adverse outcome pathways using in vitro data from open literature and continuous variables: a case example for liver fibrosis, Toxicological sciences : an official journal of the Society of Toxicology : .
- Demuynck E., Vanhaecke T., Thienpont A., Cappoen D., Goethem F. van, Winkelman L.M.T., Beltman J.B., Murugadoss S., Olsen A.-K., Marcon F., Bossa C., Shaikh S.M., Nikolopoulou D., Hatzi V., Pennings J., Luijten M., Adam-Guillermin C., Paparella M., Audebert M. & Mertens B. (2025), Advancing genotoxicity assessment by building a global AOP network, Environmental and Molecular Mutagenesis 66(6-7): 341-366.
- Plas-van Duijn A. van der, Winkelman L.M.T., Lensen C., Duivendijk M. van, Derksen I., Veenendaal J.M.F. van, Schaap G., Sluijter M., Groningen T.J.B. van, Doorn R. van, Hall T. van, Slieker R.C., Sharp T.H., Beltman J.B., Bresser K. & Scheeren F.A. (2025), Pyroglutamation of cell surface proteins CD47 and TRP1 by glutaminyl cyclase modulates therapeutic antibody binding, Communications Biology 8(1): 1561.